Medical News

RSS

Abraxis BioScience's Phase 3 trial comparing ABRAXANE with Taxol injection meets primary endpoint

Abraxis BioScience, Inc. today announced that its randomized registrational Phase 3 clinical trial comparing ABRAXANE® (protein-bound paclitaxel) with Taxol® (paclitaxel) injection, both in combination with carboplatin, met the study’s primary endpoint by demonstrating that ABRAXANE showed a significant improvement in overall response rate as compared to Taxol, in the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC), as assessed by independent radiologist review.

17 Mar 2010

SBRT improves survival in patients with inoperable non-small cell lung cancer

Highly-focused stereotactic body radiation therapy (SBRT) can eliminate the targeted tumor while avoiding treatment-related illness and may ultimately improve survival for patients with inoperable non-small cell lung cancer, according to early findings of a Radiation Therapy Oncology Group study published in the March 17 cancer-themed issue of the Journal of the American Medical Association.

17 Mar 2010

Public health experts review planning outreach to populations vulnerable to HIV infection and STBBI

Public health experts from across Canada will meet in Toronto March 11 and 12 to review and discuss planning outreach to populations vulnerable to HIV infection and sexually transmitted and blood borne infections (STBBI). The meeting will be hosted by Winnipeg's National Collaborating Centre for Infectious Diseases.

17 Mar 2010

Meridian Bioscience revises fiscal 2010 guidance, expects net sales between $145M and $153M

Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it is revising downward its previous sales and earnings guidance for the fiscal year ending September 30, 2010. This action is being taken as a result of weaker than expected operating results for the second quarter ending March 31, 2010, based on preliminary results to date. Separately, Meridian announced that it will file a 510(k) for FDA marketing clearance next week in connection with its illumigene™ C. difficile product.

17 Mar 2010

SBRT may improve survival rates for lung-cancer patients: Study

A radiation therapy that uses multiple radiation beams to target tumors precisely has been shown to eliminate the primary tumor and ultimately may improve survival rates for lung-cancer patients unable to undergo surgery, according to UT Southwestern Medical Center physicians who led a national clinical trial of the treatment.

17 Mar 2010

China Sky One Medical's 2009 fourth-quarter total revenues up 15.0%

China Sky One Medical, Inc., a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced financial results for the fourth quarter and fiscal year ended December 31, 2009. The Company also announced its earnings guidance for full year 2010.

17 Mar 2010

IRIS International announces the launch of new and improved corporate website

IRIS International, Inc., a leading manufacturer of urinalysis systems and consumables for use in hospitals and commercial laboratories worldwide, announced today the launch of its new and improved corporate website at www.proiris.com, featuring a newly designed homepage and enhanced navigation tools with access to the latest company information.

17 Mar 2010

StockPreacher.com: ACAD reports net loss of $8.7M for fourth-quarter of 2009

StockPreacher.com announces an investment report featuring ACADIA Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

17 Mar 2010

Full Medicare coverage for IVF: CFAS felicitates Quebec government

The Canadian Fertility and Andrology Society (CFAS) congratulates Premier Jean Charest and his Government on their announcement of full Medicare coverage for in-vitro fertilization treatments in Quebec.

17 Mar 2010

Renhuang Pharmaceuticals' net income for first-quarter of 2010 increases 17.8%

Renhuang Pharmaceuticals, Inc., a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines, today announced its financial results for the first quarter ended January 31, 2010.

17 Mar 2010

Research confirms benefits of PET scan in early detection of Alzheimer's disease

Westside Medical Associates of Los Angeles and Westside Medical Imaging (WMI) of Beverly Hills announce the benefit of early positron emission tomography (PET) scanning to identify Alzheimer's in its early more treatable phase.

17 Mar 2010

Schiff Nutrition International third-quarter net sales increase to 53.3M

Schiff Nutrition International, Inc., today announced results for the fiscal 2010 third quarter and nine months ended February 28, 2010. The company also announced plans to return $0.50 per share to shareholders through a special cash dividend payable on April 14, 2010 to shareholders of record at the close of business on March 31, 2010.

17 Mar 2010

Protalix BioTherapeutics commences clinical trial of human acetylcholinesterase for biodefense indications

Protalix BioTherapeutics, Inc. announced today that it has initiated a phase I clinical trial of PRX-105, the Company's plant cell expressed pegylated recombinant human acetylcholinesterase product candidate in development for biodefense indications. The trial is designed to study the safety of PRX-105 by administering a bolus intravenous injection of PRX-105 in healthy volunteers.

17 Mar 2010

New chemotherapy agents improve survival time for patients with metastatic colorectal cancer

New chemotherapy agents appear associated with improvements in survival time for patients with metastatic colorectal cancer but at substantial cost.

17 Mar 2010

Human Genome Sciences announces Phase 2 results of mapatumumab combination therapy for NSCLC

Human Genome Sciences, Inc. today announced the results of its randomized Phase 2 trial of mapatumumab (HGS-ETR1) in combination with the chemotherapy agents paclitaxel and carboplatin as first-line therapy in advanced non-small cell lung cancer (NSCLC).

17 Mar 2010

Palomar SlimLipo body sculpting laser to be featured on The Dr. Oz Show

Palomar Medical Technologies, Inc., a leading researcher and developer of lasers and pulsed-light systems for aesthetic treatments, is pleased to announce that the Palomar SlimLipo body sculpting laser will be featured on The Dr. Oz Show on Wednesday, March 17.

17 Mar 2010

AHF’s Magic Johnson ‘Testing America’ Tour arrives in Nashville to offer free HIV testing

AHF’s Magic Johnson ‘Testing America’ Tour, a six month, 48 state national cross country HIV testing tour, arrives in Nashville, Tennessee and will offer free HIV testing, along with local partner Street Works at events today and tomorrow.

17 Mar 2010

Stomach wrap operations more effective than acid suppression tablets in severe acid reflux treatment

Stomach wrap operations may be more effective than acid suppression tablets in the treatment of severe acid reflux, according to a new Cochrane Systematic Review. The study shows a more pronounced improvement in symptoms shortly after surgery than with drug treatment.

17 Mar 2010

Greatbatch Medical's OptiSeal Valved PTFE Peelable Introducer receives 510(k) clearance

Greatbatch Medical announced today that it has received regulatory clearance for its next generation valved peelable introducer used in the delivery of leads and catheters into the venous system. OptiSeal™ Valved PTFE Peelable Introducer achieved regulatory clearance on Monday, March 15, 2010, representing the first 510(k) regulatory approval under the Greatbatch Medical brand. It is also approved in Canada and CE marked for distribution in Europe.

17 Mar 2010

First Edition: March 17, 2010

Today's news continues to focus on Democratic leaders' efforts to finalize their health reform package and gather the votes necessary to gain House passage.

17 Mar 2010

Medical News

Abraxis BioScience's Phase 3 trial comparing ABRAXANE with Taxol injection meets primary endpoint

SBRT improves survival in patients with inoperable non-small cell lung cancer

Public health experts review planning outreach to populations vulnerable to HIV infection and STBBI

Meridian Bioscience revises fiscal 2010 guidance, expects net sales between $145M and $153M

SBRT may improve survival rates for lung-cancer patients: Study

China Sky One Medical's 2009 fourth-quarter total revenues up 15.0%

IRIS International announces the launch of new and improved corporate website

StockPreacher.com: ACAD reports net loss of $8.7M for fourth-quarter of 2009

Full Medicare coverage for IVF: CFAS felicitates Quebec government

Renhuang Pharmaceuticals' net income for first-quarter of 2010 increases 17.8%

Research confirms benefits of PET scan in early detection of Alzheimer's disease

Schiff Nutrition International third-quarter net sales increase to 53.3M

Protalix BioTherapeutics commences clinical trial of human acetylcholinesterase for biodefense indications

New chemotherapy agents improve survival time for patients with metastatic colorectal cancer

Human Genome Sciences announces Phase 2 results of mapatumumab combination therapy for NSCLC

Palomar SlimLipo body sculpting laser to be featured on The Dr. Oz Show

AHF’s Magic Johnson ‘Testing America’ Tour arrives in Nashville to offer free HIV testing

Stomach wrap operations more effective than acid suppression tablets in severe acid reflux treatment

Greatbatch Medical's OptiSeal Valved PTFE Peelable Introducer receives 510(k) clearance

First Edition: March 17, 2010

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News